Clinical Trial Update: Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

View source ↗

Summary

Pfizer-sponsored trial evaluated safety and effects of tofacitinib in combination with biologic DMARDs in people with rheumatoid arthritis; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (Xeljanz) (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2025-06-08